Related references
Note: Only part of the references are listed.Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and meta-analysis
Satoshi Ida et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Pharmacological HIF inhibition prevents retinal neovascularization with improved visual function in a murine oxygen-induced retinopathy model
Yukihiro Miwa et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Molecular association model of PPAR alpha and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARM alpha
Yuta Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Fibroblast Growth Factor 21 Protects Photoreceptor Function in Type 1 Diabetic Mice
Zhongjie Fu et al.
DIABETES (2018)
Effects of Pemafibrate, a Novel Selective PPAR alpha Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
Eiichi Araki et al.
DIABETES CARE (2018)
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Hidenori Arai et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
Hemal Mehta et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice
Masaya Araki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Roles of Hypoxia Response in Retinal Development and Pathophysiology
Toshihide Kurihara
KEIO JOURNAL OF MEDICINE (2018)
Fibroblast Growth Factor 21-Metabolic Role in Mice and Men
Harald Staiger et al.
ENDOCRINE REVIEWS (2017)
FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice
Zhongjie Fu et al.
CELL REPORTS (2017)
661W is a retinal ganglion precursor-like cell line in which glaucoma-associated optineurin mutants induce cell death selectively
Zuberwasim Sayyad et al.
SCIENTIFIC REPORTS (2017)
Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice
Kenta Takei et al.
JOURNAL OF DIABETES INVESTIGATION (2017)
Hypoxia-induced metabolic stress in retinal pigment epithelial cells is sufficient to induce photoreceptor degeneration
Toshihide Kurihara et al.
ELIFE (2016)
Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis
Yan Gong et al.
EBIOMEDICINE (2016)
Transcriptome Analysis of K-877 (a Novel Selective PPAR alpha Modulator (SPPARM alpha))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver
Sana Raza-Iqbal et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
Ocular Anti-VEGF Therapy for Diabetic Retinopathy: Overview of Clinical Efficacy and Evolving Applications
Ning Cheung et al.
DIABETES CARE (2014)
Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
Juan E. Grunwald et al.
OPHTHALMOLOGY (2014)
PPARα Regulates Mobilization and Homing of Endothelial Progenitor Cells Through the HIF-1α/SDF-1 Pathway
Zhongxiao Wang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
Ying Chen et al.
DIABETES (2013)
An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes
Jonathan E. Noonan et al.
DIABETES (2013)
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
Toshio Suda et al.
CELL STEM CELL (2011)
von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina
Toshihide Kurihara et al.
DEVELOPMENT (2010)
Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.
Emily Y. Chew et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis
Kip M. Connor et al.
NATURE PROTOCOLS (2009)
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
A. C. Keech et al.
LANCET (2007)
Glycoxidized particles mimic lipofuscin accumulation in aging eyes: a new age-related macular degeneration model in rabbits
Tsutomu Yasukawa et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2007)
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors
Philippe Gervois et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
VEGF164 is proinflammatory in the diabetic retina
S Ishida et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Vascular endothelial growth factors and angiogenesis in eye disease
AN Witmer et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2003)
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
T Nishimura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)
Share Paper
